573
Views
11
CrossRef citations to date
0
Altmetric
Original Research Article

The effect of a drospirenone-containing combined oral contraceptive on female sexual function: a prospective randomised study

, , , , , & show all
Pages 395-400 | Received 08 Mar 2016, Accepted 20 Jul 2016, Published online: 18 Aug 2016

References

  • Davis AR, Castaño PM. Oral contraceptives and libido in women. Annu Rev Sex Res. 2004;15:297–320.
  • Battaglia C, Battaglia B, Mancini F, et al. Sexual behavior and oral contraception: a pilot study. J Sex Med. 2012;9:550–557.
  • Fataneh G, Marjan MH, Nasrin R, et al. Sexual function in Iranian women using different methods of contraception. J Clin Nurs. 2013;22:3016–3023.
  • Burrows LJ, Basha M, Goldstein AT. The effects of hormonal contraceptives on female sexuality: a review. J Sex Med. 2012;9:2213–2223.
  • Zahumensky J, Zverina J, Sottner O, et al. Comparison of labor course and women’s sexuality in planned and unplanned pregnancy. J Psychosom Obstet Gynecol. 2008;29:159–165.
  • Sanders SA, Graham CA, Bass JL, et al. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception. 2001;64:51–58.
  • Committee on Gynecologic Practice, American College of Obstetricians and Gynecologists. Over-the-counter access to oral contraceptives. Committee Opinion No. 544. Obstet Gynecol. 2012;120:1527–1531.
  • Davis AR, Castaño PM. Oral contraceptives and sexuality. In: Goldstein I, Meston CM, Davis S, et al. editors. Women’s sexual function and dysfunction. Study, diagnosis and treatment. London: Taylor and Francis; 2006. p. 290–296.
  • Pastor Z, Holla K, Chmel R. The influence of combined oral contraceptives on female sexual desire: a systematic review. Eur J Contracept Reprod Health Care. 2013;18:27–43.
  • Guay AT, Spark R. Pathophysiology of sex steroids in women. In: Goldstein I, Meston CM, Davis S, et al. editors. Women’s sexual function and dysfunction. Study, diagnosis and treatment. London: Taylor and Francis; 2006. p. 218–228.
  • Traish AM, Kim NN. Modulation of female genital sexual arousal by sex steroid hormones. In: Goldstein I, Meston CM, Davis S, et al. editors. Women’s sexual function and dysfunction. Study, diagnosis and treatment. London: Taylor and Francis; 2006. p. 181–193.
  • World Health Organization. Medical eligibility criteria for contraceptive use. 4th ed. Geneva: WHO; 2010. p. 16–27.
  • Rosen R, Brown C, Heiman J, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26:191–208.
  • Daker-White G. Reliable and valid self-report outcome measures in sexual (dys)function: a systematic review. Arch Sex Behav. 2002;31:197–209.
  • Jonušienė G, Žilaitienė B, Adomaitienė V, et al. The Female Sexual Function Index. The methodology for the assessment of female function in a sample of Lithuanian women in postmenopause the Female Sexual Function Index. Baltic Endocrinol. 2012;6:18–22.
  • Wiegel M, Meston C, Rosen R. The Female Sexual Function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005;31:1–20.
  • Wallwiener M, Wallwiener LM, Seeger H, et al. Effects of sex hormones in oral contraceptives on the female sexual function score: a study in German female medical students. Contraception. 2010;82:155–159.
  • Enzlin P, Weyers S, Janssens D, et al. Sexual functioning in women using levonorgestrel-releasing intrauterine systems as compared to copper intrauterine devices. J Sex Med. 2012;9:1065–1073.
  • Smith NK, Jozkowski KN, Sanders SA. Hormonal contraception and female pain, orgasm and sexual pleasure. J Sex Med. 2014;11:462–470.
  • Martin-Loeches M, Ortí RM, Monfort M, et al. A comparative analysis of the modification of sexual desire of users of oral hormonal contraceptives and intrauterine contraceptive devices. Eur J Contracept Reprod Health Care. 2003;8:129–134.
  • Bancroft J, Loftus J, Long JS. Distress about sex: a national survey of women in heterosexual relationships. Arch Sex Behav. 2003;32:193–208.
  • Shahnazi M, Bayatipayan S, Khalili AF, et al. Comparing the effects of the second-and third-generation oral contraceptives on sexual functioning. Iran J Nurs Midwifery Res. 2015;20:47–55.
  • Sadovsky R, Nusbaum M. Sexual health inquiry and support is a primary care priority. J Sex Med. 2006;3:3–11.
  • Lewis RW, Fugl-Meyer KS, Bosch R, et al. Epidemiology/risk factors of sexual dysfunction. J Sex Med. 2004;1:35–39.
  • Cullberg J. Mood changes and menstrual symptoms with different gestagen/estrogen combinations. A double blind comparison with a placebo. Acta Psychiatr Scand Suppl. 1972;236:1–86.
  • Wiegratz I, Kutschera E, Lee JH, et al. Effect of four different oral contraceptives on various sex hormones and serum-binding globulins. Contraception. 2003;67:25–32.
  • Wallwiener CW, Wallwiener LM, Seeger H, et al. Prevalence of sexual dysfunction and impact of contraception in female German medical students. J Sex Med. 2010;7:2139–2148.
  • Traish AM, Kim N, Stankovic M, et al. Testosterone increases blood flow and expression of androgen and estrogen receptors in the rat vagina. J Sex Med. 2007;4:609–619.
  • Labrie F, Nelanger P, Berubč R, et al. Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. J Steroid Biochem Mol Biol. 2006;99:182–188.
  • Roberts SC, Little AC, Burriss RP, et al. Partner choice, relationship satisfaction, and oral contraception: the congruency hypothesis. Psychol Sci. 2014;25:1497–1503.
  • Davis SR, Tran J. Testosterone influences libido and well-being in women. Trends Endocrinol Metab. 2001;12:33–37.
  • Caruso S, Agnello C, Intelisano G, et al. Sexual behavior of women taking low-dose oral contraceptive containing 15 microg ethinylestradiol/60 microg gestodene. Contraception. 2004;69:237–240.
  • Caruso S, Agnello C, Intelisano G, et al. Prospective study on sexual behavior of women using 30 microg ethinylestradiol and 3 mg drospirenone oral contraceptive. Contraception. 2005;72:19–23.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.